In vivo characterization of a novel phenylisothiocyanate tropane analog at monoamine transporters in rat brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 2, 2008, Pages 587-595

  Murthy, Vishakantha ^a   Martin, Thomas J ^a   Kim, Susy ^a   Davies, Huw M L ^b   Childers, Steven R ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BETA PROPANOYL 3 BETA (2 NAPHTHYL) 8 (4 ISOTHIOCYANATOBENZYL)NORTROPANE; 2 BETA PROPANOYL 3 BETA (2 NAPHTHYL) 8 BENZYLNORTROPANE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CITALOPRAM; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; HD 205; HD 206; IODINE 125; MU OPIATE RECEPTOR; NEUROTRANSMITTER TRANSPORTER; PHENYL ISOTHIOCYANATE; SEROTONIN TRANSPORTER; TRITIUM; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING ASSAY; BRAIN MEMBRANE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG SCREENING; IN VIVO STUDY; INTRASTRIATAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TISSUE SECTION;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOTHIOCYANATES; MALE; MOLECULAR STRUCTURE; MOTOR ACTIVITY; NORTROPANES; PROTEIN BINDING; RATS; RATS, INBRED F344; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TROPANES;

EID: 47949131446     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.138842     Document Type: Article

References (42)

1. Bennett BA, Wichems CH, Hollingsworth CK, Davies HM, Thornley C, Sexton T, and Childers SR (1995) Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. J Pharmacol Exp Ther 272:1176-1186.
2. Boja JW, Carroll FI, Rahman MA, Philip A, Lewin AH, and Kuhar MJ (1990) New, potent cocaine analogs: ligand binding and transport studies on rat striatum. Eur J Pharmacol 184:329-332.
3. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12:27-36.
4. Boja JW, Patel A, Carroll FI, Rahman MA, Philip A, Lewin AH, Kopajtic TA, and Kuhar MJ (1991a) [125I]RTI-55: a potent ligand for dopamine transporters. Eur J Pharmacol 194:133-134.
5. Boja JW, Rahman MA, Philip A, Lewin AH, Carroll FI, and Kuhar MJ (1991b) Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter. Mol Pharmacol 39:339-345.
6. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, and Di Chiara G (2001) Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 141:1-4.
7. Carroll FI, Howard JL, Howell LL, Fox BS, and Kuhar MJ (2006) Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse. AAPS J 8:E196-E203.
8. Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S, Quan N, Stephens RL, Hill ER, Nottoli T, et al. (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci U S A 103:9333-9338.
9. 3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. J Pharmacol Exp Ther 242:364-371.
10. Daunais JB, Hart SL, Smith HR, Letchworth SR, Davies HM, Sexton T, Bennett BA, Childers SR, and Porrino LJ (1998) Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane 2β-propranoyl-3β-(2-naphthyl)-tropane. J Pharmacol Exp Ther 285:1246-1254.
11. David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, and Gardier AM (2003) Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br J Pharmacol 140:1128-1136.
12. Davies HM, Saikali E, Huby NJ, Gilliat VJ, Matasi JJ, Sexton T, and Childers SR (1994) Synthesis of 2-β-acyl-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. J Med Chem 37:1262-1268.
13. Davies HM, Saikali E, Sexton T, and Childers SR (1993) Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum. Eur J Pharmacol 244:93-97.
14. Desai RI, Kopajtic TA, Koffarnus M, Newman AH, and Katz JL (2005) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25:1889-1893.
15. Fleckenstein AE, Kopajtic TA, Boja JW, Carroll FI, and Kuhar MJ (1996a) Highly potent cocaine analogs cause long-lasting increases in locomotor activity. Eur J Pharmacol 311:109-114.
16. Fleckenstein AE, Pögün S, Carroll FI, and Kuhar MJ (1996b) Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 (3β-(3p- chlorophenyl)tropan-2β-carboxylic acid p- isothiocyanatophenylethyl ester hydrochloride). J Pharmacol Exp Ther 279:200-206.
17. Hemby SE, Co C, Reboussin D, Davies HM, Dworkin SI, and Smith JE (1995) Comparison of a novel tropane analog of cocaine, 2β-propanoyl-3β-(4- tolyl)tropane (PTT) with cocaine HCl in rats: nucleus accumbens extracellular dopamine concentration and motor activity. J Pharmacol Exp Ther 273:656-666.
18. Husbands SM, Izenwasser S, Loeloff RJ, Katz JL, Bowen WD, Vilner BJ, and Newman AH (1997) Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1- piperazinyl)propyl]-carbazol (rimcazole): irreversible ligands for the dopamine transporter. J Med Chem 40:4340-4346.
19. 1A receptor binding site inactivation and turnover. Brain Res Brain Res Protoc 1:364-370.
20. Kimmel HL, Carroll FI, and Kuhar MJ (2000) Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76. Neuropharmacology 39:578-585.
21. Kimmel HL, Carroll FI, and Kuhar MJ (2001) RTI-76, an irreversible inhibitor of dopamine transporter binding, increases locomotor activity in the rat at high doses. Brain Res 897:157-163.
22. 3H]PTT), for dopamine transport sites in rat brain. J Pharmacol Exp Ther 293:686-696.
23. Lever JR, Zou MF, Parnas ML, Duval RA, Wirtz SE, Justice JB, Vaughan RA, and Newman AH (2005) Radioiodinated azide and isothiocyanate derivatives of cocaine for irreversible labeling of dopamine transporters: synthesis and covalent binding studies. Bioconjug Chem 16:644-649.
24. Martin TJ, Buechler NL, Kahn W, Crews JC, and Eisenach JC (2004) Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat. Anesthesiology 101:191-203.
25. Martin TJ, McIntosh S, and Smith JE (2006) Alkylation of opioid receptors by 5′-naltrindole-isothiocyanate injected into the nucleus accumbens of rats: receptor selectivity and anatomical diffusion. Synapse 60:384-391.
26. Murthy V, Davies HM, Hedley SJ, and Childers SR (2007) Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain. Biochem Pharmacol 74:336-344.
27. O'Connor KA, Gregg TC, Davies HM, and Childers SR (2005) Effects of long-term biogenic amine transporter blockade on receptor/G-protein coupling in rat brain. Neuropharmacology 48:62-71.
28. O'Connor KA, Porrino LJ, Davies HM, and Childers SR (2005) Time-dependent changes in receptor/G-protein coupling in rat brain following chronic monoamine transporter blockade. J Pharmacol Exp Ther 313:510-517.
29. 125I]MFZ 2-24 implicates proximity of cocaine and substrate active sites. Mol Pharmacol 73:1141-1150.
30. Porrino LJ, Migliarese K, Davies HM, Saikali E, and Childers SR (1994) Behavioral effects of the novel tropane analog, 2β-propanoyl-3β-(4- tolyl)tropane (PTT). Life Sci 54:PL511-PL517.
31. 35S]GTPγS binding in rat striatal membranes. Biochem Pharmacol 57:155-162.
32. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223.
33. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, and Caron MG (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1:132-137.
34. 35S]thio]-triphosphate binding. Proc Natl Acad Sci U S A 92:7242-7246.
35. 1A receptor-activated G-proteins in rat brain. Brain Res Bull 44:39-45.
36. Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, Meltzer PC, Martin J, Rauch S, and Fischman AJ (2007) Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry 62:1059-1061.
37. Tatsumi M, Groshan K, Blakely RD, and Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
38. Tella SR, Ladenheim B, Andrews AM, Goldberg SR, and Cadet JL (1996) Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. J Neurosci 16: 7416-7427.
39. Vaughan RA, Gaffaney JD, Lever JR, Reith ME, and Dutta AK (2001) Dual incorporation of photoaffinity ligands on dopamine transporters implicates proximity of labeled domains. Mol Pharmacol 59:1157-1164.
40. Vaughan RA, Parnas ML, Gaffaney JD, Lowe MJ, Wirtz S, Pham A, Reed B, Dutta SM, Murray KK, and Justice JB (2005) Affinity labeling the dopamine transporter ligand binding site. J Neurosci Methods 143:33-40.
41. 125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter. J Biol Chem 282:8915-8925.
42. Vicentic A, Battaglia G, Carroll FI, and Kuhar MJ (1999) Serotonin transporter production and degradation rates: studies with RTI-76. Brain Res 841:1-10.